Skip to content
Menu
Wicked Sister
Wicked Sister

Have we found a marker to target problematic B cells

Posted on February 25, 2026 by

Tweet Kuiper KL, Bogers L, Rip J, van Hasselt Y, Melief MJ, Wierenga-Wolf AF, Klein Kranenbarg RAM, Bindels E, van de Werken HJG, de Beukelaar J, Smets I, Wokke B, Smolders J, van Luijn MM. Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2026 May;13(3):e200553.  Simple answer is no…

+

From our CEO

Posted on February 25, 2026 by

The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au

+

Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS

Posted on February 25, 2026 by

The post Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au

+

My psychiatrist had some deep thoughts today

Posted on February 24, 2026 by

I have monthly appointments with a psychiatrist where I mainly discuss my experience with sleep medications that he prescribes for me. You see, I struggle with serial insomnia hence the regular appointments with the shrink. In the course of our meeting, we talk about lots of things including my experience with daily living. I admitted…

+

New MS initiative gives patients a stronger voice in research priorities

Posted on February 24, 2026 by

The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research. sp The initiative, called Prioritized Research Agenda Development and Advancement (PRADA), creates a structured, collaborative process through which people living with MS can…

+

New real-world study supports long-term Ocrevus use in relapsing MS

Posted on February 24, 2026 by

In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low during follow-up. At four years, 39.7% of patients with available…

+

Is riding a bus bad for your health?

Posted on February 24, 2026 by

Tweet Now the title of this post seemingly has nothing to do with the content of the paper, but what this new paper says is air poluution is bad for you. We say NSS. However is it the air pollution that is the issue or is it something that is more causal, but relates to…

+

M&M: Merck, Mayo Clinic team up to use AI to speed drug development in MS

Posted on February 23, 2026 by

Merck and Mayo Clinic have launched a research collaboration to use artificial intelligence (AI) and large-scale clinical data to accelerate drug discovery and development, with an initial focus on diseases with high unmet needs, including multiple sclerosis (MS). The partnership will combine Mayo’s extensive clinical and genomic datasets with Merck’s AI-enabled research technologies. The Merck…

+

Connection and Compassion: My MS Journey

Posted on February 23, 2026 by

By Dr. Eva Jackson Seeking Answers and Facing Uncertainty For many years, my health declined, and I found myself searching desperately for answers. Ireached out to my healthcare team, at times pleading for their help to uncover what was causingmy … Continue reading → Source: blog.mymsaa.org

+

Childhood bacteria..was does it tell us about the cause of MS.

Posted on February 23, 2026 by

Tweet mmmmM…my favourite subject….Yep my Bad…I don’t know the back end of a flagelleum from the front end…So I will do like every respecting cheat and use AI rather than reading and ask it to tell me what the important bacteria in MS are. Here is the answer (from Google) “Multiple sclerosis (MS) is associated…

+
  • 1
  • 2
  • 3
  • 4
  • …
  • 76
  • Next

Recent Posts

  • Have we found a marker to target problematic B cells
  • From our CEO
  • Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS
  • My psychiatrist had some deep thoughts today
  • New MS initiative gives patients a stronger voice in research priorities

Recent Comments

    Archives

    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • February 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • July 2019

    Categories

    • Multiple Sclerosis Research
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    NAVBAR

    Archive 1

    MS Search

    Recent

      ©2026 Wicked Sister | Powered by Superb Themes